2020 American Transplant Congress
Morbidity in Lung Transplant for Connective Tissue Disease
*Purpose: To evaluate the post-lung transplant comorbidities of patients with connective tissue disease (CTD) compared with an age-matched cohort of patients transplanted for idiopathic pulmonary…2020 American Transplant Congress
Chronic Lymphocytic Leukemia in a Lung Transplant Recipient
*Purpose: Malignancy is generally a contraindication to lung transplantation (LTx). Few reports describe clinical outcomes in patients undergoing solid-organ transplantation with indolent hematologic malignancy. We…2020 American Transplant Congress
The Outcomes of Pancreas Transplantation from Pediatric Donors: A Single Center Experience
*Purpose: For increasing pancreas donor pool, the use of pediatric donors for pancreas transplantation is considered as a suitable option. However, the following questions still…2020 American Transplant Congress
Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation
*Purpose: Predictive models capable of identifying patients at risk for readmission are in development. However, it is unknown how accurate clinicians are at predicting early…2020 American Transplant Congress
Rouleaux Formation in Human Livers During Normothermic Machine Perfusion
*Purpose: We recently discovered that red blood cells form rouleaux plugs in human kidney vasculature during normothermic machine perfusion (NMP) and are associated with poor…2020 American Transplant Congress
Targeting CD62 – CD162 Signaling with a Soluble Form of a Tandem-PSGL-1 in a Murine Model of Hindlimb Transplantation
*Purpose: Static cold storage (SCS) times for organs and tissues are currently limited to hours. Once outside the body, tissues lack oxygen and nutrient supply…2020 American Transplant Congress
Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3
Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX
*Purpose: Current dosing recommendations for the administration of basiliximab on post-operative days (POD) 0 and 4 stem from two phase 3 renal transplant studies. Limited…2020 American Transplant Congress
Kidney Transplant from Sickle Cell Donors
University of Mississippi, Jackson, MS
*Purpose: Patients with End-stage renal disease have an increased risk of death. Dialysis and kidney transplantation are the only treatments. Patients who receive kidney transplantation…2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
1UCSF, San Francisco, CA, 2UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…2020 American Transplant Congress
De Novo DSA in the Setting of Stable Renal Allograft Function Does Not Impair Long-Term Graft Survival
*Purpose: To determine the long-term outcome of renal allograft recipients with de novo DSA (dnDSA) in the setting of stable allograft function.*Methods: A single-center review…
- « Previous Page
- 1
- …
- 93
- 94
- 95
- 96
- 97
- …
- 223
- Next Page »